| Stage | SBUX | % of rev | BROS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.3B | 100.00% | $551M | 100.00% | SBUX ×16.92 |
| Gross profit | $2.3B | 24.64% | $151M | 27.42% | BROS +2.8pp |
| Operating income | $980M | 10.52% | $70M | 12.78% | BROS +2.3pp |
| Pre-tax income | $1.4B | 15.22% | $64M | 11.66% | SBUX +3.6pp |
| Net income | $1.0B | 11.21% | $52M | 9.37% | SBUX +1.8pp |
| Stage | SBUX | BROS | Gap · A − B |
|---|---|---|---|
| Revenue | $9.3B100.00% | $551M100.00% | SBUX ×16.92 |
| Gross profit | 24.64%$2.3B | 27.42%$151M | BROS +2.8pp |
| Operating income | 10.52%$980M | 12.78%$70M | BROS +2.3pp |
| Pre-tax income | 15.22%$1.4B | 11.66%$64M | SBUX +3.6pp |
| Net income |
| 11.21%$1.0B |
| 9.37%$52M |
| SBUX +1.8pp |
No shared counterparties.